${ line_item.product_title }
Dr Tiina Meder
Founder and CEO of Meder by Dr Tiina Meder (founded in 2009), dermatologist and cosmetic safety expert, an experienced lecturer and speaker on the topic of dermatology and skin care, sharing her expertise around the world in Japan, Taiwan, IMCAS Europe and China, FACE, CCR, APAN (Australia, New Zealand), LNE (France, Poland, Ukraine) and Microbiome Connection (USA) to name but a few. Across her career she has had more than 50 articles published.
GLP-1 weight-loss medicines, including Wegovy and Mounjaro, are changing the way we think about obesity, type 2 diabetes and long-term metabolic health. But alongside often significant weight loss, many people notice changes in their face and skin: hollowed cheeks, more visible lines, or skin that feels less firm than before.
If you are taking a GLP-1 medicine, or thinking about starting one, it helps to take a whole-body view. Healthy weight management is not simply about becoming smaller. It is also about protecting muscle, supporting your skin, maintaining energy and feeling well in your changing body.
GLP-1 is short for glucagon-like peptide-1, a natural hormone released by the gut after you eat. It helps your body manage blood glucose, slows digestion and helps you feel fuller for longer.
Medicines such as semaglutide and tirzepatide work by copying or enhancing some of these hormonal signals. In the UK, Wegovy contains semaglutide and is licensed for weight management in eligible adults, while Mounjaro contains tirzepatide and is licensed for both type 2 diabetes and weight management. Ozempic also contains semaglutide, but it is licensed in the UK for type 2 diabetes rather than weight management.
These are prescription medicines, not beauty treatments. The MHRA advises that GLP-1 medicines should be used for their licensed medical purposes, with appropriate clinical support—not simply for cosmetic or aesthetic weight loss.
For people living with obesity, diabetes or weight-related health conditions, these medicines can be an important part of a wider health plan. In the NHS, access is subject to clinical eligibility criteria and is paired with dietary, physical-activity and specialist weight-management support.
You may have heard the phrase “Ozempic face”. It is not a medical diagnosis, and it does not refer to one specific medicine. It is an informal term used to describe facial changes that can happen after substantial or rapid weight loss.
The face is supported by bone, muscles, connective tissue and layers of fat. When fat volume decreases quickly, the skin may need time to adapt to its new shape. This can make the following features more noticeable:
This is not necessarily a direct effect of GLP-1 medication on the skin. In many cases, it is the visible result of losing facial fat faster than the skin and underlying tissues can remodel. Reviews of the emerging research suggest that changes may also involve complex interactions between fat tissue, stem cells and fibroblasts — the skin cells involved in collagen and extracellular-matrix production.
It may, at least to a degree. Skin adapts slowly, and people often see some improvement after their weight has stabilised. However, the extent of recovery depends on age, genetics, skin quality, sun exposure, smoking history, hormonal changes and how quickly weight has been lost.
You may be more likely to notice skin laxity if you:
The aim is not to be frightened of weight loss. It is to make the process as well-supported and sustainable as possible. Skincare can improve comfort, hydration and the appearance of skin quality, but it cannot replace significant lost facial volume.
A lower number on the scales does not tell the whole story. Weight loss can include lean mass as well as fat, and muscle is essential for strength, mobility, posture, metabolic health and healthy ageing.
Talk to the clinician managing your treatment about a plan that includes:
During weight loss, your skin does not necessarily need more aggressive treatments. It usually needs more comfort, hydration and consistency. If your skin is dry, tight, reactive or irritated, simplify your routine rather than introducing several strong active ingredients at once.
Start with:
For a simple Meder routine, use Net-Apax Cleansing Mask as a gentle cleansing step, followed by Soin-Apax Antioxidant Serum. Complete the routine with a Meder moisturiser selected for dry, oily, sensitive or mature skin.
Retinoids can be valuable ingredients, but rapid weight loss may not be the ideal moment to suddenly increase retinol strength or frequency—particularly if the skin feels dry or sensitive.
Vita-Long Skin Longevity Active Care is designed for daily use to support skin vitality, comfort and the appearance of facial volume. It combines antioxidants, prebiotics, probiotics, cyclic peptides and plant extracts with plant-derived Volufiline, an ingredient used to support the appearance of fuller-looking facial contours.
A simple routine may include:
Broad-spectrum SPF every morning
Arma-Lift Mask once a week to support the appearance of skin firmness and elasticity
GLP-1 medicines can be life-changing for people with obesity, diabetes and weight-related health risks. They deserve to be treated as powerful medical therapies, with proper prescribing, nutrition, movement and follow-up care—not as a shortcut to a smaller dress size.
The more helpful question is not, “Will GLP-1 weight loss make me look older?” It is: “How can I support my health, strength, skin and confidence while my body changes?”
That is the active skin longevity approach: supporting comfortable, resilient, healthy-looking skin while caring for the whole person behind it.
“Ozempic face” is an informal, non-medical phrase used to describe facial changes that may become more noticeable after substantial weight loss. These may include hollowing in the cheeks or temples, more defined folds around the mouth, reduced softness around the jawline or skin that appears less firm. It is not exclusive to Ozempic, and it is not necessarily a direct side effect of one medicine. In many cases, the visible change is linked to how much facial fat has been lost and how quickly the skin and underlying tissues can adapt.
Not necessarily. Wegovy and Mounjaro can support significant weight loss in eligible people, and a rapid reduction in facial fat can make the face look more hollow or less supported. This may create the impression of accelerated ageing. How noticeable these changes are depends on many factors, including your age, natural facial structure, skin elasticity, sun exposure, smoking history, hormonal stage and the pace of weight loss. For many people, improved metabolic health remains the more important long-term outcome.
It may improve to some extent after your weight has stabilised. Skin remodelling is gradual and can continue for several months. Younger skin and skin with good baseline elasticity may adapt more easily. However, significant loss of facial or body volume cannot always be fully reversed with skincare alone. Hydration, sun protection and barrier-supportive skincare can improve comfort and the appearance of skin quality, but they cannot replace lost fat or structural volume.
Weight loss can include lean mass as well as fat. Maintaining muscle is especially important for strength, mobility, posture, metabolic health and healthy ageing. Discuss your nutrition and activity plan with the clinician prescribing your medicine. Depending on your individual health needs, this may include adequate protein intake, resistance or strength training, regular walking, aerobic activity, mobility work, good sleep and recovery. Do not follow a generic protein target if you have kidney disease or another condition that affects dietary requirements.
During a period of rapid body change, a calm and consistent routine is often more useful than aggressive exfoliation or frequently changing products. If your skin feels dry, tight, reactive or uncomfortable, focus on hydration and barrier support. Use a gentle cleanser, a hydrating antioxidant serum, a moisturiser matched to your skin type and broad-spectrum sunscreen in the morning. Add a deeply hydrating mask once or twice a week when skin needs additional comfort. Avoid introducing multiple strong active ingredients at the same time.
For a simple Meder routine, use Net-Apax Cleansing Mask, followed by Soin-Apax Antioxidant Serum, Vita-Long Skin Longevity Active Care, and a Meder moisturiser suited to your skin. Finish your morning routine with broad-spectrum SPF.
You do not necessarily need to stop using retinol simply because you are taking a GLP-1 medicine. However, a weight-loss period may not be the best time to increase retinol strength, use it more often or combine it with several exfoliating products. If your skin is dry, irritated, tight or uncomfortable, it may be wise to pause retinol temporarily and prioritise hydration and barrier comfort. You may also consider gentler retinol alternatives, such as peptides, bakuchiol, antioxidants and barrier-supportive ingredients.
No topical skincare product can replace substantial facial fat loss or restore anatomical volume. However, skincare can support skin comfort, hydration, barrier function, elasticity and the appearance of plumper skin while your body changes. Vita-Long Skin Longevity Active Care is designed to support skin vitality, comfort and the appearance of fuller-looking facial contours. It can be used alongside a gentle cleanser, antioxidant serum, moisturiser and daily broad-spectrum SPF as part of an active skin longevity routine.
Gentle professional treatments may support skin comfort, circulation and the appearance of skin quality and firmness, although results and suitability vary. Microcurrent, red LED light therapy, hydrating facials and selected energy-based treatments may be considered with a qualified practitioner. At home, microcurrent therapy can be used over any Meder Active Mask. Always follow the manufacturer’s instructions, including guidance on conductive products, treatment settings, contraindications and treatment frequency. If your skin barrier is dry, sensitised or irritated, prioritise hydration and comfort before adding stimulating treatments. For significant facial volume loss, seek advice from a qualified medical aesthetic practitioner, as facials and devices cannot replace lost structural volume.
GLP-1 medicines are prescription treatments for specific medical indications and should be used only with appropriate clinical supervision. In the UK, the MHRA advises that these medicines should be used for their licensed purposes and obtained through legitimate healthcare channels — not bought from unregulated online sellers or used casually as a cosmetic shortcut. The most sustainable approach to weight management combines suitable medical care with nutrition, movement, muscle support, sleep, emotional wellbeing and patience.